Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03830320 · ClinicalTrials.gov registry record · Phase 1
Positron Emission Tomography (PET) Imaging of Thrombosis
A Phase 1 study of Cancer and Atrial Fibrillation, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 165
- Enrollment target
- 1
- Study location
NCT03830320 is a Phase 1 study of Cancer and Atrial Fibrillation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 165 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03830320, a Phase 1 study of Cancer and Atrial Fibrillation, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 165 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasive alternative to the current standard-of-care methods.
Conditions Studied
Interventions
- PROCEDURE Electrocardiogram
- DRUG [64Cu]FBP8
- DEVICE PET/MR
- PROCEDURE Blood Collection
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2016-04-01 |
| Est. Completion | 2027-01-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03830320
The ClinicalTrials.gov registry entry for NCT03830320 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 4 interventions - of which Electrocardiogram is the first listed.
NCT03830320 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03830320 about?
NCT03830320 is a clinical study titled "Positron Emission Tomography (PET) Imaging of Thrombosis". The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invasi...
What is the current status of trial NCT03830320?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 165 participants. The study started on 2016-04-01. Estimated completion is 2027-01-31.
What conditions does trial NCT03830320 study?
This clinical trial studies the following conditions: Cancer, Atrial Fibrillation, COVID-19, Thrombosis.
What interventions are being tested in trial NCT03830320?
The interventions under investigation include: Electrocardiogram (PROCEDURE), [64Cu]FBP8 (DRUG), PET/MR (DEVICE), Blood Collection (PROCEDURE).
Who is sponsoring clinical trial NCT03830320?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03830320 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Impact of Daily Oral Cannabis Doses in Patients With Cancer
RECRUITING · Phase 1
-
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.